-+ 0.00%
-+ 0.00%
-+ 0.00%

CUE BIOPHARMA SHARES JUMP 48.2% PREMARKET AFTER POSITIVE RESULTS FROM MID-STAGE STUDY FOR CUE-221 IN HIVES TREATMENT

Reuters·09/21/2026 08:21:11

Please log in to view news